Bakakos, P.; Chatziapostolou, P.; Katerelos, P.; Efstathopoulos, P.; Korkontzelou, A.; Katsaounou, P.
Extrafine Beclometasone Dipropionate/Formoterol NEXThaler on Device Usability, Adherence, Asthma Control and Quality of Life. A Panhellenic Prospective, Non-Interventional Observational Study in Patients with Asthma—The NEXT-Step Study. J. Pers. Med. 2022, 12, 146.
https://doi.org/10.3390/jpm12020146
AMA Style
Bakakos P, Chatziapostolou P, Katerelos P, Efstathopoulos P, Korkontzelou A, Katsaounou P.
Extrafine Beclometasone Dipropionate/Formoterol NEXThaler on Device Usability, Adherence, Asthma Control and Quality of Life. A Panhellenic Prospective, Non-Interventional Observational Study in Patients with Asthma—The NEXT-Step Study. Journal of Personalized Medicine. 2022; 12(2):146.
https://doi.org/10.3390/jpm12020146
Chicago/Turabian Style
Bakakos, Petros, Panagiotis Chatziapostolou, Panos Katerelos, Petros Efstathopoulos, Aliki Korkontzelou, and Paraskevi Katsaounou.
2022. "Extrafine Beclometasone Dipropionate/Formoterol NEXThaler on Device Usability, Adherence, Asthma Control and Quality of Life. A Panhellenic Prospective, Non-Interventional Observational Study in Patients with Asthma—The NEXT-Step Study" Journal of Personalized Medicine 12, no. 2: 146.
https://doi.org/10.3390/jpm12020146
APA Style
Bakakos, P., Chatziapostolou, P., Katerelos, P., Efstathopoulos, P., Korkontzelou, A., & Katsaounou, P.
(2022). Extrafine Beclometasone Dipropionate/Formoterol NEXThaler on Device Usability, Adherence, Asthma Control and Quality of Life. A Panhellenic Prospective, Non-Interventional Observational Study in Patients with Asthma—The NEXT-Step Study. Journal of Personalized Medicine, 12(2), 146.
https://doi.org/10.3390/jpm12020146
